
PHARMANUTRA PR - PHN PRELIMINARY REVENUES 2023: insider trades · Italy · Consob
CONSOB:pharmanutra-pr-phn-preliminary-revenues-2023ITIT·ConsobMcap 862M€Healthcare
Discover the full insider trade history of PHARMANUTRA PR - PHN PRELIMINARY REVENUES 2023, a listed issuer based in Italy. Shares are listed on IT IT, under the supervision of Consob. Operating in the Healthcare sector, PHARMANUTRA PR - PHN PRELIMINARY REVENUES 2023 has logged 1 public disclosures. Market capitalisation: €861.8m. The latest transaction was disclosed on 11 January 2024 — Other. Among the most active insiders: Unknown. The full history is free.
Financial data
FY ended December 2025 · cache
Analyst consensus
3 analysts76.00 €Target 81.33 €(-10%)86.00 €
Income statement
Revenue132.9 M€
Gross profit102.9 M€77% margin
Net income20.0 M€15.2% margin
Valuation
PER (trailing)40.9x
PER (forward)29.4x
P/Book12.1x
Balance sheet & cash
Market cap861.8 M€
Total debt20.5 M€
Free Cash Flow16.4 M€
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.1%
% insiders65.0%
% institutions16.1%
Last declaration on 11 January 2024